Boswellia

BCCT plans to write a summary on Boswellia (Indian frankincense). While our summary is in development, you can visit these sites for more information:

Clinical Practice Guidelines

According to the Society for Integrative Oncology’s 2009 clinical practice guidelines, there is insufficient evidence to recommend boswellia for relieving radiation therapy-induced toxicities.1

Managing Side Effects and Promoting Wellness

Managing or relieving side effects or symptoms, reducing treatment toxicity, supporting quality of life or promoting general well-being

Boswellia is promoted for for relief of radiation therapy-induced toxicity.

Cautions

Common adverse events include gastrointestinal symptoms and contact dermatitis. Some herb-drug interactions are possible. See the About Herbs summary above for details. BCCT recommends consulting with your physician and pharmacist if you are thinking about taking this natural product.

Dosing

BCCT does not recommend therapies or doses, but only provides information for patients and providers to consider as part of a complete treatment plan. Patients should discuss therapies with their physicians, as contraindications, interactions and side effects must be evaluated.

Dosage recommendations are available from these sources:

Integrative Plans, Protocols and Medical Systems

For more information about plans and protocols, see our Integrative Plans and Protocols page.

View All References

More Information

Enter your comments or questions below.

Comments (0)




Allowed tags: <b><i><br>Add a new comment: